Competitive and sandwich immunoassays were applied for the quantification of fetuin B and clusterin within 15 min at detection limits of 0.24 nM and 0.12 nM, respectively, thus providing a rapid and sensitive paper-based device that could be used for the detection of multiple AD biomarkers to achieve a more effective AD diagnosis [51]. This evidence concerns the gene CLU and Alzheimer disease.